TEL AVIV, Israel - Cancer treatments have come a long way since the disease's discovery. Despite these exciting advancements, there is one unfortunately common cancer who's treatment options are lagging behind the rest: Pancreatic Cancer. Pancreatic cancer is – you guessed it – cancer of the pancreas. This is the small organ just behind the
NEW YORK - Scientists have discovered a new way to destroy cancer cells. Stimulating aminocyanine molecules with near-infrared light caused them to vibrate in sync, enough to break apart the membranes of cancer cells. Aminocyanine molecules are already used in bioimaging as synthetic dyes. Commonly used in low doses to detect cancer, they stay stable in water and are
DAVIS, Ca. - Scientists have just discovered a way to kill off cancerous cells, a new process that could improve cancer treatment. A research team from the University of California, Davis (UCD) Comprehensive Cancer Center has found a method to detonate the mechanism that leads to the heart of cancerous tumors. The result, which was
LONDON - Artificial intelligence has developed a treatment for an aggressive form of cancer in just 30 days and demonstrated it can predict a patient's survival rate using doctors' notes. The breakthroughs were performed by separate systems, but show how the powerful technology's uses go far beyond the generation of images and text. University of Toronto
OXFORD, UK - A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound. Oxford University researchers have worked in collaboration with industry leaders NuCana to assess a novel
NEW YORK - In what appears to be a very promising breakthrough for the treatment of rectal cancer, a small drug trial conducted in the US found every patient treated in the experiment had their cancer successfully go into remission. The medication given, called dostarlimab and sold under the brand name Jemperli, is an immunotherapy drug used
ANN ARBOR - Swift Biosciences, a pioneer in the development of Next-Generation Sequencing library preparation genomics kits for academic, translational, and clinical research, has been acquired by Integrated DNA Technologies, an Iowa-based comprehensive genomics solutions provider. Terms were not announced. IDT develops and makes nucleic acid products for academic and commercial research, agriculture, medical diagnostics,
ANN ARBOR - A University of Michigan startup that's developing a non-invasive way to remove diseased tissue from cancer patients using high-intensity ultrasound has attracted $8.3 million in Series B financing. The investment will help advance clinical trials of HistoSonics' Robotic Assisted Sonic Therapy—an innovative tissue-destruction technology targeted for liver cancer and other solid tumor
